StockData
Integra LifeSciences Holdings Corp logo

Integra LifeSciences Holdings Corp (IART) stock

IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/308% below fair value
$13.55−0.43 (-3.08%)

Close on Nov 17, 2026Market cap $1.05BP/E 79.7Yield –

Integra LifeSciences cash

Cash and short-term investments held at the end of each period.

Integra LifeSciences's cash was $311.93M at Sep 30, 2026. For fiscal 2025 it was $263.74M, down 3.6% from the year before. Over ten years it grew 18.5% a year on average. The highest annual figure on record is $513.45M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$263.74M-3.6%
FY2024Dec 31, 2024$273.57M-11.5%
FY2023Dec 31, 2023$309.10M-32.3%
FY2022Dec 31, 2022$456.66M-11.1%
FY2021Dec 31, 2021$513.45M+9.2%
FY2020Dec 31, 2020$470.17M+136.4%
FY2019Dec 31, 2019$198.91M+43.3%
FY2018Dec 31, 2018$138.84M-20.6%
FY2017Dec 31, 2017$174.94M+71.4%
FY2016Dec 31, 2016$102.06M+112.0%
FY2015Dec 31, 2015$48.13M-32.9%
FY2014Dec 31, 2014$71.73M-40.5%
FY2013Dec 31, 2013$120.61M+24.4%
FY2012Dec 31, 2012$96.94M-3.8%
FY2011Dec 31, 2011$100.81M-21.7%
FY2010Dec 31, 2010$128.76M+79.1%
FY2009Dec 31, 2009$71.89M-60.8%
FY2008Dec 31, 2008$183.55M+220.1%
FY2007Dec 31, 2007$57.34M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$311.93M+16.4%
Q2 FY2026Jun 30, 2026$274.08M+8.1%
Q1 FY2026Mar 31, 2026$265.50M-2.9%
Q4 FY2025Dec 31, 2025$263.74M-3.6%
Q3 FY2025Sep 30, 2025$267.88M-3.5%
Q2 FY2025Jun 30, 2025$253.61M-14.6%
Q1 FY2025Mar 31, 2025$273.30M-58.8%
Q4 FY2024Dec 31, 2024$273.57M-11.5%
Q3 FY2024Sep 30, 2024$277.60M+1.4%
Q2 FY2024Jun 30, 2024$296.93M-4.0%
Q1 FY2024Mar 31, 2024$663.10M+115.7%
Q4 FY2023Dec 31, 2023$309.10M-32.3%
Q3 FY2023Sep 30, 2023$273.73M-46.5%
Q2 FY2023Jun 30, 2023$309.19M-30.9%
Q1 FY2023Mar 31, 2023$307.37M-24.5%
Q4 FY2022Dec 31, 2022$456.66M-11.1%
Q3 FY2022Sep 30, 2022$511.94M+8.9%
Q2 FY2022Jun 30, 2022$447.15M+12.5%
Q1 FY2022Mar 31, 2022$407.09M-0.5%
Q4 FY2021Dec 31, 2021$513.45M+9.2%
Q3 FY2021Sep 30, 2021$470.23M+18.7%
Q2 FY2021Jun 30, 2021$397.41M+10.1%
Q1 FY2021Mar 31, 2021$408.98M+14.3%
Q4 FY2020Dec 31, 2020$470.17M+136.4%
Q3 FY2020Sep 30, 2020$396.28M+90.5%
Q2 FY2020Jun 30, 2020$360.98M+105.0%
Q1 FY2020Mar 31, 2020$357.71M+127.8%
Q4 FY2019Dec 31, 2019$198.91M+43.3%
Q3 FY2019Sep 30, 2019$207.98M+1.0%
Q2 FY2019Jun 30, 2019$176.08M-4.2%
Q1 FY2019Mar 31, 2019$157.03M-17.1%
Q4 FY2018Dec 31, 2018$138.84M-20.6%
Q3 FY2018Sep 30, 2018$205.99M-57.3%
Q2 FY2018Jun 30, 2018$183.77M+18.9%
Q1 FY2018Mar 31, 2018$189.40M+39.9%
Q4 FY2017Dec 31, 2017$174.94M+71.4%
Q3 FY2017Sep 30, 2017$481.94M–
Q2 FY2017Jun 30, 2017$154.60M–
Q1 FY2017Mar 31, 2017$135.40M–
Q4 FY2016Dec 31, 2016$102.06M–

More Integra LifeSciences figures

See a number that looks wrong?